US
CA
NZ
UK
AU
IND
Last update at 2025-02-13T19:12:18.004332Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Income before tax | -4.76176M | 1.76M | -3.14446M | - |
| Minority interest | - | - | - | - |
| Net income | -5.36143M | 1.69M | -3.01410M | - |
| Selling general administrative | 7.11M | 7.64M | 8.63M | - |
| Selling and marketing expenses | - | - | - | - |
| Gross profit | 2.53M | 7.11M | 5.57M | - |
| Reconciled depreciation | 0.45M | 0.58M | 0.62M | - |
| Ebit | -4.57998M | -0.52682M | -3.06218M | -2.77402M |
| Ebitda | - | - | - | - |
| Depreciation and amortization | - | - | - | - |
| Non operating income net other | - | - | - | - |
| Operating income | -4.57998M | -0.52682M | -3.06218M | - |
| Other operating expenses | - | - | 1.10M | 1.10M |
| Interest expense | 0.19M | 0.12M | 0.06M | - |
| Tax provision | 0.60M | 0.07M | -0.13036M | - |
| Interest income | 0.00018M | 0.00023M | 0.00065M | - |
| Net interest income | -0.19127M | -0.11574M | -0.06403M | - |
| Extraordinary items | - | - | - | - |
| Non recurring | - | - | - | - |
| Other items | - | - | - | - |
| Income tax expense | 0.60M | 0.07M | -0.13036M | 0.03M |
| Total revenue | 27.05M | 36.28M | 31.89M | - |
| Total operating expenses | 31.63M | 36.81M | 34.96M | - |
| Cost of revenue | 24.52M | 29.17M | 26.32M | - |
| Total other income expense net | 0.00949M | 2.40M | -0.01825M | - |
| Discontinued operations | - | - | - | - |
| Net income from continuing ops | -5.36143M | 1.69M | -3.01410M | - |
| Net income applicable to common shares | -5.36143M | 1.69M | -3.01410M | -2.10968M |
| Preferred stock and other adjustments | - | - | - | - |
| Breakdown | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Total assets | 19.67M | 17.70M | 19.67M | - |
| Intangible assets | - | - | - | - |
| Earning assets | - | - | - | - |
| Other current assets | 1.92M | 0.27M | 0.23M | 0.24M |
| Total liab | 14.44M | 7.12M | 10.79M | - |
| Total stockholder equity | 5.23M | 10.58M | 8.88M | - |
| Deferred long term liab | - | - | - | - |
| Other current liab | 0.91M | 0.58M | 2.83M | 0.56M |
| Common stock | 0.05M | 0.05M | 0.05M | 0.05M |
| Capital stock | 0.05M | 0.05M | 0.05M | - |
| Retained earnings | -22.36066M | -16.99923M | -18.68642M | -15.67232M |
| Other liab | 0.48M | - | 0.52M | - |
| Good will | - | - | - | - |
| Other assets | 0.23M | 0.58M | 0.64M | 0.50M |
| Cash | 3.32M | 0.73M | 2.60M | - |
| Cash and equivalents | - | - | - | - |
| Total current liabilities | 5.98M | 7.11M | 8.93M | 3.56M |
| Current deferred revenue | - | - | - | - |
| Net debt | - | 1.35M | - | - |
| Short term debt | - | - | - | - |
| Short long term debt | 2.47M | 2.08M | 1.04M | - |
| Short long term debt total | - | - | - | - |
| Other stockholder equity | - | - | - | - |
| Property plant equipment | 3.36M | 3.74M | 4.16M | 4.00M |
| Total current assets | 16.08M | 13.38M | 14.87M | 10.95M |
| Long term investments | - | - | - | - |
| Net tangible assets | 5.23M | 10.58M | 8.88M | 11.89M |
| Short term investments | - | - | - | - |
| Net receivables | 2.37M | 2.94M | 3.12M | 3.18M |
| Long term debt | - | - | 1.33M | - |
| Inventory | 8.47M | 9.45M | 8.93M | 7.33M |
| Accounts payable | 1.21M | 1.90M | 2.94M | 1.47M |
| Total permanent equity | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - |
| Additional paid in capital | - | - | - | - |
| Common stock total equity | - | - | - | - |
| Preferred stock total equity | - | - | - | - |
| Retained earnings total equity | - | - | - | - |
| Treasury stock | - | - | - | - |
| Accumulated amortization | - | - | - | - |
| Non currrent assets other | 0.23M | - | - | - |
| Deferred long term asset charges | - | - | - | - |
| Non current assets total | 3.59M | 4.32M | 4.80M | - |
| Capital lease obligations | 0.00830M | 0.01M | 0.02M | - |
| Long term debt total | - | - | - | - |
| Breakdown | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Investments | -0.07504M | -0.16716M | -0.61781M | - |
| Change to liabilities | -0.35122M | -3.29770M | 3.60M | 0.19M |
| Total cashflows from investing activities | -0.07504M | -0.16716M | -0.61781M | -0.61781M |
| Net borrowings | 8.49M | 2.08M | 2.37M | 2.37M |
| Total cash from financing activities | 8.49M | 2.08M | 2.37M | 2.37M |
| Change to operating activities | -0.97651M | -0.08295M | 1.11M | 0.06M |
| Net income | -5.36143M | 1.69M | -3.01410M | -2.10968M |
| Change in cash | 4.32M | -1.87386M | 2.40M | 0.06M |
| Begin period cash flow | 0.73M | 2.60M | 0.20M | - |
| End period cash flow | 5.05M | 0.73M | 2.60M | 0.20M |
| Total cash from operating activities | -4.09636M | -3.78414M | 0.65M | 0.06M |
| Issuance of capital stock | - | - | - | - |
| Depreciation | 0.45M | 0.58M | 0.62M | 0.82M |
| Other cashflows from investing activities | - | - | - | - |
| Dividends paid | - | - | - | - |
| Change to inventory | 0.98M | -0.52204M | -1.59559M | 0.50M |
| Change to account receivables | 0.56M | 0.16M | 0.04M | 0.56M |
| Sale purchase of stock | - | - | - | - |
| Other cashflows from financing activities | - | - | - | - |
| Change to netincome | 0.60M | -2.30555M | -0.11471M | 0.04M |
| Capital expenditures | 0.08M | 0.17M | 0.62M | 0.62M |
| Change receivables | - | - | - | - |
| Cash flows other operating | - | - | - | - |
| Exchange rate changes | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - |
| Change in working capital | 0.22M | -3.74525M | 3.16M | - |
| Stock based compensation | 0.02M | 0.01M | 0.00242M | - |
| Other non cash items | - | - | - | - |
| Free cash flow | -4.17139M | -3.95130M | 0.03M | - |
Sector: Healthcare Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to EBITDA (x) | |
|---|---|---|---|---|---|---|---|---|
| AHPIQ Allied Healthcare Products Inc. |
- -% | - | - | - | - | - | 0.20 | |
| ABT Abbott Laboratories |
0.24 0.18% | 135.86 | 37.15 | 23.15 | 4.67 | 4.97 | 4.88 | 19.38 |
| SYK Stryker Corporation |
3.15 0.83% | 380.45 | 44.07 | 24.94 | 5.51 | 6.12 | 6.05 | 25.73 |
| MDT Medtronic PLC |
1.26 1.44% | 88.53 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| BSX Boston Scientific Corp |
2.30 2.31% | 102.04 | 68.17 | 24.57 | 5.85 | 4.26 | 6.46 | 26.80 |
Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company offers respiratory care/anesthesia products, including air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers, as well as respiratory disposable products, such as oxygen tubing products, facemasks, cannulas, and ventilator circuits; and home respiratory care products comprising aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, portable suction equipment, and a line of respiratory disposable products. It also provides medical gas equipment, which includes construction products consisting of in-wall medical system components, central station pumps and compressors, and headwalls; regulation devices and suction equipment comprising flowmeters, vacuum regulators, and pressure regulators, as well as related adapters, fittings, and hoses that measure, regulate, monitor, and transfer medical gases from walled piping or equipment to patients in hospital rooms, operating theaters, and intensive care areas; and disposable oxygen cylinders to provide oxygen for short periods. In addition, the company offers emergency medical products that include respiratory/resuscitation products, such as demand resuscitation valves, portable resuscitation systems, bag masks and related products, emergency transport ventilators, precision oxygen regulators, minilators, multilators, and humidifiers; and trauma and patient handling products that include spine immobilization products, pneumatic anti-shock garments, and trauma burn kits. It serves hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, emergency medical products dealers, and others. The company was incorporated in 1979 and is headquartered in Chicago, Illinois. On May 8, 2023, Allied Healthcare Products, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court
55 Monroe St., Chicago, IL, United States, 60603
| Name | Title | Year Born |
|---|---|---|
| Mr. Daniel C. Dunn | VP of Finance, CFO, Secretary & Treasurer | 1959 |
| Mr. Kevin D. Kroupa | Vice President of Operations | 1959 |
| Mr. Akash Amin | President & Chief Restructuring Officer | 1992 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...